SCHEMBL22340700

SCHEMBL22340700

CCN(Cc1ccccc1)Cc1ccc(OC)cc1

nearest known ligand 0.75

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.75
MAPK1 P28482 1/20 0.75
L3MBTL1 Q9Y468 1/20 0.60
LTA4H P09960 2/20 0.60
NPC1 O15118 1/20 0.57
POLB P06746 1/20 0.57
BCHE P06276 3/20 0.55
ACHE P22303 3/20 0.54
CNR2 P34972 2/20 0.53
KDM4E B2RXH2 2/20 0.53
CNR1 P21554 1/20 0.52
G6PC1 P35575 1/20 0.51
TDP1 Q9NUW8 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
HTT P42858 1/20 0.50
SIGMAR1 Q99720 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16701049 0.90 LTA4H (0.67) TSHRMAPK1LTA4HNPC1POLB
SCHEMBL28778941 0.90 LTA4H (0.67) TSHRMAPK1LTA4HNPC1POLB
SCHEMBL12128183 0.89 BCHE (0.62) TSHRMAPK1L3MBTL1LTA4HNPC1
SCHEMBL12128228 0.89 BCHE (0.62) TSHRMAPK1L3MBTL1LTA4HNPC1
SCHEMBL10076308 0.88 HRH3 (0.61) TSHRMAPK1
SCHEMBL12763727 0.86 CNR2 (0.67) TSHRMAPK1L3MBTL1BCHEACHE
SCHEMBL13699118 0.84 TSHR (0.79) TSHRMAPK1BCHEACHEKDM4E
SCHEMBL375111 0.84 KDM4E (0.68) TSHRMAPK1L3MBTL1BCHECNR2
Acetic Acid SCHEMBL23429845 0.82 HRH3 (0.56) TSHRMAPK1L3MBTL1NPC1POLB
SCHEMBL16706897 0.82 LTA4H (0.56) TSHRMAPK1LTA4HNPC1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3707132-B1 NEW METHOD FOR THE SYNTHESIS OF UNSYMMETRICAL TERTIARY AMINES UNIV PARIS SACLAY (FR) 2024-07-17 EP disclosed
US-11034646-B2 Method for the synthesis of unsymmetrical tertiary amines Universite Paris-Saclay (FR) 2021-06-15 US disclosed
US-20200255369-A1 NEW METHOD FOR THE SYNTHESIS OF UNSYMMETRICAL TERTIARY AMINES Universite Paris-Saclay (FR) 2020-08-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200255369-A1 NEW METHOD FOR THE SYNTHESIS OF UNSYMMETRICAL TERTIARY AMINES ADH1C, ADH1A, ADH5 TSHR 1107/4885MAPK1 2759/4885L3MBTL1 4036/4885
US-11034646-B2 Method for the synthesis of unsymmetrical tertiary amines ADH1C, PNMT, ADH1A TSHR 1103/4885MAPK1 2759/4885L3MBTL1 3863/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.